WO2024127333 - CYTOTOXIC COMPOUNDS
National phase entry is expected:
Publication Number
WO/2024/127333
Publication Date
20.06.2024
International Application No.
PCT/IB2023/062734
International Filing Date
14.12.2023
Title **
[English]
CYTOTOXIC COMPOUNDS
[French]
COMPOSÉS CYTOTOXIQUES
Applicants **
PHEON THERAPEUTICS LTD
Inventors
ANDRIOLLO, Paolo
PROCOPIOU, George
JACKSON, Paul
Priority Data
63/387,436
14.12.2022
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 3612 | |
| EPO | Filing, Examination, Granting | 23871 | |
| Japan | Filing, Examination, Granting | 2917 | |
| South Korea | Filing, Examination, Granting | 3516 | |
| USA | Filing, Examination, Granting | 10640 |
Total:
44,556
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
The present disclosure provides compounds having a 6-7-5 membered ring or 6-7-6 membered ring comprising a 1,4-benzodiazepine ring comprising an A ring and an imine nitrogen, wherein a hydrogen bond donor, a hydrogen bond acceptor, an electron withdrawing group, or an electron donating group is present on the A ring at a position para to the imine nitrogen, and conjugates thereof useful for treating cancer.[French]
La présente invention concerne des composés ayant un cycle à 6-7-5 chaînons ou un cycle à 6-7-6 chaînons comprenant un cycle 1,4-benzodiazépine comprenant un cycle et un azote imine, un donneur de liaison hydrogène, un accepteur de liaison hydrogène, un groupe attracteur d'électrons, ou un groupe donneur d'électrons étant présent sur le cycle à une position para par rapport à l'azote imine, et des conjugués de ceux-ci utiles pour le traitement du cancer.